Articles
-
1 month ago |
onlinelibrary.wiley.com | Lucio N. Gordan |Rohan Medhekar |Alex Z. Fu |Mostafa Shokoohi
1 Introduction Multiple myeloma (MM) makes up 1.8% of all cancer diagnosis in the US, with an incidence rate of 7.0 per 100,000 individuals [1]. MM is a multifactorial disease with risk factors such as male sex, increased age, prior family history, pernicious anemia, genetic factors, and occupational factors [2].
-
1 month ago |
blackchronicle.com | Lucio N. Gordan
Nearly every American’s life has been touched by cancer in some way. The American Cancer Society estimates more than 2 million people will be diagnosed with cancer in 2025, with over 171,000 of those cases in Florida. As an oncologist to the Florida community, I have seen that access to treatment, cost of care, and being close to supportive family and friends are critical factors in a patient’s fight against cancer. Community oncologists are focused on building trust with patients.
-
1 month ago |
thecentersquare.com | Lucio N. Gordan
Nearly every American’s life has been touched by cancer in some way. The American Cancer Society estimates more than 2 million people will be diagnosed with cancer in 2025, with over 171,000 of those cases in Florida. As an oncologist to the Florida community, I have seen that access to treatment, cost of care, and being close to supportive family and friends are critical factors in a patient’s fight against cancer. Community oncologists are focused on building trust with patients.
-
2 months ago |
onclive.com | Vivek Subbiah |Lucio N. Gordan
OpinionVideoFebruary 17, 2025Author(s):,Panelists discuss how in this discussion the top 3 key points were patient-centric care, enhanced multidisciplinary coordination, and increased access and equity. In the next 3 to 5 years there will be more decentralized testing, potentially more practices participating in genomic profiling, the cost of testing will go down and the turnaround time will be shorter.
-
Feb 10, 2025 |
onclive.com | Vivek Subbiah |Lucio N. Gordan
OpinionVideoFebruary 10, 2025Author(s):,Panelists discuss how decentralizing testing can address socioeconomic disparities by improving access to diagnostics for underserved populations. In-house testing reduces barriers like transportation challenges, lack of insurance, and limited availability of specialized tests, ensuring timely, equitable health care for all communities.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 98
- Tweets
- 42
- DMs Open
- No
FCS medical oncologist Martin Dietrich, MD, PhD shares promising new treatment discoveries using immunotherapy and targeted therapy for stage III non-small cell lung cancer with OncLive® On Air. https://t.co/gcWtv3bqRx
A survey of more than 6,800 FCS patients conducted this month found that patients overwhelmingly prefer that their care providers are vaccinated and wear masks to reduce the spread of COVID-19 and provide a safe environment within clinics. https://t.co/UPMghcwoeA
The @US_FDA has fully approved the first COVID-19 vaccine, the @pfizer-BioNTech COVID-19 Vaccine. https://t.co/luxLh1XB8X